Canada - English - Health Canada

ratiopharm inc division of teva canada limited - gabapentin - tablet - 800mg - gabapentin 800mg - miscellaneous anticonvulsants

Canada - English - Health Canada

genpharm ulc - gabapentin - capsule - 300mg - gabapentin 300mg - miscellaneous anticonvulsants

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - meloxicam - solution - 20mg - meloxicam 20mg - cattle; swine (pigs); sheep

Canada - English - Health Canada

chanelle pharmaceuticals manufacturing limited - meloxicam - solution - 20mg - meloxicam 20mg - cattle; swine (pigs); sheep

Canada - English - Health Canada

dermcare-vet pty. ltd - chlorhexidine gluconate; miconazole nitrate - solution - 20g; 20g - chlorhexidine gluconate 20g; miconazole nitrate 20g - cats; dogs

United States - English - NLM (National Library of Medicine)

padagis us llc - podofilox (unii: l36h50f353) (podofilox - unii:l36h50f353) - podofilox 5 mg in 1 ml - podofilox topical solution 0.5% is indicated for the topical treatment of external genital warts (condyloma acuminatum). this product is not indicated in the treatment of perianal or mucous membrane warts (see precautions ). although genital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. differentiating warts from squamous cell carcinoma (so-called "bowenoid papulosis") is of particular concern. squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with podofilox topical solution 0.5%. podofilox topical solution 0.5% is contraindicated for patients who develop hypersensitivity or intolerance to any component of the formulation.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - podofilox (unii: l36h50f353) (podofilox - unii:l36h50f353) - podofilox 5 mg in 1 ml - podofilox 0.5% solution is indicated for the topical treatment of external genital warts (condyloma acuminatum). this product is not indicated in the treatment of perianal or mucous membrane warts (see precautions). although genital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. differentiating warts from squamous cell carcinoma (so-called “bowenoid papulosis”) is of particular concern. squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with podofilox 0.5% solution. podofilox 0.5% solution is contraindicated for patients who develop hypersensitivity or intolerance to any component of the formulation.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - podofilox (unii: l36h50f353) (podofilox - unii:l36h50f353) - podofilox 5 mg in 1 ml - podofilox 0.5% solution is indicated for the topical treatment of external genital warts (condyloma acuminatum). this product is not indicated in the treatment of perianal or mucous membrane warts (see precautions). although genital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. differentiating warts from squamous cell carcinoma (so-called “bowenoid papulosis”) is of particular concern. squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with podofilox 0.5% solution. podofilox 0.5% solution is contraindicated for patients who develop hypersensitivity or intolerance to any component of the formulation.

Israel - English - Ministry of Health

romat ltd - sulfadimethoxine; trimethoprim - solution (oral) - trimethoprim 40 mg/g; sulfadimethoxine 200 mg/g - broilers and turkeys: treatment of respiratory and urogenital infections caused by micro-organisms gram-positive and gram-negative sensitive to sulfamides and trimethoprim.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - podofilox (unii: l36h50f353) (podofilox - unii:l36h50f353) - podofilox 0.5% solution is indicated for the topical treatment of external genital warts (condyloma acuminatum). this product is not indicated in the treatment of perianal or mucous membrane warts (see precautions). although genital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. differentiating warts from squamous cell carcinoma (so-called “bowenoid papulosis”) is of particular concern. squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with podofilox 0.5% solution. podofilox 0.5% solution is contraindicated for patients who develop hypersensitivity or intolerance to any component of the formulation.